Transcatheter pulmonary valve imlantation after surgical correction of right ventricular outflow tract: the experience of one center
https://doi.org/10.51922/2616-633X.2022.6.1.1555
Abstract
Transcatheter pulmonary valve implantation (TPVI) is a relatively new method of treating patients with right ventricular outflow tract (RVOT) dysfunction after surgical treatment of congenital heart defects. Since its introduction in 2000 by Bonhoeffer, more than ten thousand of such procedures have been performed worldwide. Currently two types of valves are available in the Republic of Belarus: Melody TPVMedtronic and Edwards Sapien. TPVI is safe and effective in the majority of patients with RVOT dysfunction and in some selected patients with patched RVOT. The low complication rate and the reduced number of open-chest re-interventions over a patient’s lifetime are among the main advantages of the procedure. The article presents a literature review, and summarizes the experience and results of TPVI performed on 24 patients in the Republican Centre of Pediatric Surgery.
About the Authors
P. Charnahlaz
Republican Centre of Pediatric Surgery
Belarus
Belarus
Minsk
V. Kadochkin
Republican Centre of Pediatric Surgery
Belarus
Belarus
Minsk
Y. Linnik
Republican Centre of Pediatric Surgery
Belarus
Belarus
Minsk
K. Drozdovski
Republican Centre of Pediatric Surgery
Belarus
Belarus
Minsk
References
1. Verheugt C.L., Uiterwaal C., van der Velde E.T., Meijboom F.J., Pieper P.G., van Dijk A.P., Vliegen H.W., Grobbee D.E., Mulder B.J. Mortality in adult congenital heart disease. Eur Heart J, 2010, vol. 31, no. 10, pp. 1220–1229.
2. Giugno L., Faccini A., Carminati M. Percutaneous Pulmonary Valve Implantation. Korean Circ J, 2020, vol. 50, no. 4, pp. 302–316. doi.org/10.4070/kcj.2019.0291.
3. CHernoglaz P.F. Tetrada Fallo – «Staryj» porok v XXI veke – nereshennye voprosy etapnoj hirurgicheskoj korrekcii [Fallo’s Tetrada – “Old” Malformation in the XXI century – Unresolved Issues of Staged Surgical Correction]. Neotlozh. kardiologiya i kardiovaskulyar. riski, 2021, vol. 5, no. 1, pp. 1210–1216. (in Russian).
4. Homann M., Haehnel J.C., Mendler N., Paek S.U., Holper K., Meisner H., Lange R. Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts. Eur J Cardiothorac Surg, 2000, vol. 17, no. 6, pp. 624-630.
5. Dearani J.A., Danielson G.K., Puga F.J., Schaff H.V., Warnes C.W., Driscoll D.J., Schleck C.D., Ilstrup D.M. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg, 2003, vol. 75, no. 2, pp. 399-410.
6. Boethig D, Goerler H, Westhoff-Bleck M, et al. Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years. Eur J Cardiothorac Surg, 2007, vol. 32, pp. 133-141.
7. Lindberg H.L., Saatvedt K., Seem E., Hoel T., Birkeland S. Single-center 50 years’ experience with surgical management of tetralogy of Fallot. Eur J Cardiothorac Surg, 2011, vol. 40, no. 3, pp. 538-542.
8. Bouzas B., Kilner P.J., Gatzoulis M.A. Pulmonary regurgitation: not a benign lesion. Eur Heart J, 2005, vol. 26, no. 5, pp. 433-439.
9. Shin Y.R., Jung J.W., Kim N.K., Choi J.Y., Kim Y.J., Shin H.J., Park Y.H., Park H.K. Factors associated with progression of right ventricular enlargement and dysfunction after repair of tetralogy of Fallot based on serial cardiac magnetic resonance imaging. Eur J Cardiothoracic Surg, 2016, vol. 50, no. 3, pp. 464-469.
10. Tretter J.T., Friedberg M.K., Wald R.M., McElhinney D.B. Defining and re-fining indications for transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot: contributions from anatomical and functional imaging. Int J Cardiol, 2016, vol. 221, pp. 916-925.
11. Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot the quest continues. Circulation, 2013, vol. 128, no. 17, pp. 1855-1857.
12. Bonhoeffer P., Boudjemline Y., Saliba Z., Merckx J., Aggoun Y., Bonnet D., Acar P., Le Bidois J., Sidi D. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet, 2000, vol. 356, no. 9239, pp. 1403-1405.
13. Medtronic Inc. Indications, Contraindications, Warnings, Precautions and Adverse Events: MelodyVR Transcatheter Pulmonary-Valve and EnsembleVR Transcatheter Delivery System. Medtronic, IncInternational Section, 2009 [electronic resource]. Available at: http://www.medtronic.com/intl/melody/melody_warn.html. (accessed 16.03.2022).
14. Garay F., Webb J., Hijazi Z.M. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv, 2006, vol. 67, pp. 659-662.
15. Demkow M., Biernacka E.K., Spiewak M., Kowalski M., Siudalska H., Wolski P., Sondergaard L., Miśko J., Hoffman P., Rużyłło W. Percutaneous pulmonary valve implantation preceded by routine presenting with a bare metal stent. Catheter Cardiovasc Interv, 2011, vol. 77, no. 3, pp. 381-389.
16. Cardoso R., Ansari M., Garcia D., Sandhu S., Brinster D., Piazza N. Prestenting for prevention of melody valve stent fractures: a systematic review and meta-analysis. Catheter Cardiovasc Interv, 2016, vol. 87, no. 3, pp. 534-539.
17. Baumgartner H., Bonhoeffer P., De Groot N.M.S., de Haan F., Deanfield J.E., Galie N., Gatzoulis M.A., Gohlke-Baerwolf C., Kaemmerer H., Kilner P., Meijboom F., Mulder B.J., Oechslin E., Oliver J.M., Serraf A., Szatmari A., Thaulow E., Vouhe P.R., Walma E. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J, 2010, vol. 31, no. 23, pp. 2915-2957.
18. Baumgartner H., De Backer J., Babu-Narayan S.V., Budts W., Chessa M., Diller G.P., Lung B., Kluin J., Lang I.M., Meijboom F., Moons P., Mulder B.J.M., Oechslin E., Roos-Hesselink J.W., Schwerzmann M., Sondergaard L., Zeppenfeld K. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J, 2021, vol. 42, no. 6, pp. 563-645. doi: 10.1093/eurheartj/ehaa554.
19. Stout K.K., Daniels C.J., Aboulhosn J.A., Bozkurt B., Broberg C.S., Colman J.M., Crumb S.R., Dearani J.A., Fuller S., Gurvitz M., Khairy P., Landzberg M.J., Saidi A., Valente A.M., Van Hare G.F. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines. Circulation, 2019, vol. 139, no. 14, pp. e637-e800.
20. Silversides C.K., Marelli A., Beauchesne L., Dore A., Kiess M., Salehian O., Bradley T., Colman J., Connelly M., Harris L., Khairy P., Mital S., Niwa K., Oechslin E., Poirier N., Schwerzmann M., Taylor D., Vonder Muhll I., Baumgartner H., Benson L., Celermajer D., Greutmann M., Horlick E., Landzberg M., Meijboom F., Mulder B., Warnes C., Webb G., Therrien J. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol, 2010, vol. 26, no. 3, pp. 143-150.
Review
For citations:
Charnahlaz P., Kadochkin V., Linnik Y., Drozdovski K. Transcatheter pulmonary valve imlantation after surgical correction of right ventricular outflow tract: the experience of one center. Emergency Cardiology and Cardiovascular Risks journal. 2022;6(1):1555-1562. (In Russ.) https://doi.org/10.51922/2616-633X.2022.6.1.1555
Views:
7
Email this article 